Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide—for type 1 diabetes

Publication date: Available online 5 May 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Tatjana Nikolic, Jaap J Zwaginga, Bas S Uitbeijerse, Nicky J Woittiez, Eelco J de Koning, Henk-Jan Aanstoot, Bart O Roep
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research